CD44 and cancer: Although we observed reduced CD44 expression in brain metastases compared to primary lung tumors, this finding appears to contrast with previous studies reporting a critical role of CD44+ cancer-stem-cell (CSC)-derived pericyte-like cells in promoting brain metastasis [76].